Skip to main content
BMRN
NASDAQ Life Sciences

BioMarin Posts $122.8M Q3 Loss as Alesta Charge Hits Results

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$57.44
Mkt Cap
$11.119B
52W Low
$49.259
52W High
$70.98
52W Position info
17% above low
Off High info
19% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

BMRN sits 17% above its 52-week low of $49.259.

Summary

BioMarin reported a third-quarter loss of $122.8 million, or 63 cents a share. The red ink lands right where the company pre-announced it would: an 8-K on October 6th flagged a roughly $283 million pre-tax in-process R&D charge from the Alesta Therapeutics acquisition, about $1.50 per share, so the loss is largely a known accounting hit rather than a fresh operational miss. Revenue came in at $1.025 billion, up 32% from a year earlier, against Q2, when sales rose 20% year-over-year to $990 million and management raised full-year guidance. Any guidance update is the piece that will decide the stock's reaction.

At the time of this announcement, BMRN was trading at $57.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.1B. The 52-week trading range was $49.26 to $70.98. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

BMRN - Latest Insights

BMRN
Nov 03, 2026, 4:34 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $55.66
Real-time Price: $60.16 info
Change: +$4.50 (+8%) info
Market Cap: $11.897B info
BMRN
Nov 02, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $54.79
Real-time Price: $60.16 info
Change: +$5.37 (+10%) info
Market Cap: $11.897B info
BMRN
Oct 29, 2026, 8:57 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $56.40
Real-time Price: $60.16 info
Change: +$3.76 (+7%) info
Market Cap: $11.897B info
BMRN
Oct 06, 2026, 4:22 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $56.22
Real-time Price: $60.16 info
Change: +$3.94 (+7%) info
Market Cap: $11.897B info
BMRN
Aug 31, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $67.95
Real-time Price: $60.16 info
Change: -$7.79 (-11%) info
Market Cap: $11.897B info